German Ambassador to India and Bhutan, Walter J Lindner, announced that the government of Germany recognized WHO-listed Bharat Biotech’s Covid vaccine, COVAXIN, for travel to the country starting June 1.

In November last year the World Health Organization issued an emergency use listing for Covaxin, adding to a growing portfolio of vaccines validated for the prevention of COVID-19 caused by SARS-CoV-2.

COVAXIN is a whole virus inactivated COVID-19 vaccine candidate in liquid form. It is stored at 2-8 degrees Celsius, has a 12 month shelf life, and a multi-dose vial policy.

Several countries such as Australia, Japan, and Canada allow passengers vaccinated with COVAXIN to enter the country.